LIPOSORBER(R) HFE Post Approval Study

What is the trial about?

The purpose of this research study is to gather data on the LIPOSORBER® LA-15 System and determine if it is still as safe now as it was before the FDA approval.

Who can participate?

Patients who are receiving treatment with the LIPOSORBER® LA-15 System.

What is involved?

Blood samples will be collected at baseline, at the end of the treatment and at 5 follow-up visits. These blood samples will be collected at the same time as standard of care lab tests and no additional needle stick will be necessary.

Participation will continue throughout the 9 weeks of treatment and for 24 months after your child’s final LIPOSORBER® LA-15 System treatment.